arXiv ScienceSearch

arXiv · 2608.29127

Beyond Correctness: Validity-Oriented Evaluation of Biomedical LLM Judges

Abstract

We propose a scalable, validity-oriented pipeline for evaluating biomedical LLM judges when high-quality human judgments are scarce. First, we augment existing human-labelled biomedical benchmarks with deterministic, metric-grounded mutations that produce auditable preference pairs. Second, we evaluate judges beyond aggregate correctness using three deployment-relevant dimensions: correctness against metric-derived gold labels, robustness under repeated stochastic sampling, and compliance with the requested output format. We use this pipeline to assess Llama-3.1-8B-Instruct under four regimes: (1) base, using the instruct model as is; (2) SFT, distillation-based supervised fine-tuning only; (3) RL, GRPO-based reinforcement learning only; and (4) SFT$\rightarrow$RL, SFT followed by RL. The base and single-stage regimes struggle on structured medical discrimination such as PICO extraction and clinical calculations, whereas SFT$\rightarrow$RL performs best across correctness, compliance, and robustness; gains concentrate on decomposable tasks (PICO, MedCalc), at times matching or outperforming frontier models.

Explore related subjects

Keep this discovery

BibTeXRIS

Rodrigo de Oliveira, Federico Pittino, James Gwinnutt, Jay Nanavati. 2026-08-29. Beyond Correctness: Validity-Oriented Evaluation of Biomedical LLM Judges. https://arxiv.org/abs/2608.29127

Cite the original work for its findings. Save a collection to share your selection of sources.

Discover connections

Connections use source metadata and explicit phrase matches, not verified experimental comparisons.

KEEP EXPLORING

Related papers

One AI Signal, Many Human Judgments: A Bayesian Cascade Analysis of AI-based Credibility Indicators in Online Information Spread

Social media platforms increasingly use AI-based credibility indicators to help users judge misinformation. Unlike individual human-AI decision-making, these indicators are embedded in information spread: users see both an AI prediction and earlier judgments shaped by the same AI, and their own judgments may then enter the public history. Yet how to analytically characterize this process remains under-explored. We therefore introduce a social-learning lens for this setting by extending the classical Bayesian cascade model with the AI indicator as a shared public signal. The resulting Gateway condition compares the evidence from the AI prediction with users' private impressions. Through this view, we show that AI changes what public history means. Crowd agreement may reflect accumulated independent human evidence, or repeated dependence on the same AI prediction. This creates a preservation-correction trade-off: stronger reliance on AI can preserve correct predictions, but can also lock in incorrect ones by blocking corrective private impressions. We calibrate the model using human-subject data on news veracity judgments. Although the AI outperforms human users, the average user weights it below her own impression but above several peer judgments, while individual users vary from discounting the AI to relying on it enough to cascade. Simulations show that over-reliance on a weak AI is especially harmful, and that diversifying AI signals across users can better keep the crowd informative. We conclude with implications for understanding human-AI interaction in information spread and designing misinformation interventions.

cs.HC

Meta-ethics and AI: exploring the novel meta-ethical questions in the era of AI

With the development of artificial intelligence (AI), the landscape of meta-ethics, which has largely centred on human ethics, faces pressures that may significantly reconfigure it. In particular, if future AI systems were to exhibit sufficiently integrated capacities for moral reasoning, moral intentionality, and moral reflection, novel meta-ethical questions would arise concerning what I call "AI's own ethics", as distinct from ethical principles merely imposed on AI by human designers. This paper offers a conditional and methodological framework for identifying the questions that would emerge if such AI systems were to arise. On that basis, the paper distinguishes four domains of meta-ethical inquiry in the era of AI: questions about the nature of human ethics from the human perspective; questions about the nature of AI's own ethics from the human perspective; questions about the nature of human ethics from the AI perspective; and questions about the nature of AI's own ethics from the AI perspective. The paper then considers how some existing mainstream meta-ethical theories (such as cognitivism and non-cognitivism, error theory and success theory, relativism, and objective realism) might illuminate these domains, while arguing that many familiar human-centred formulations of those theories may not transfer straightforwardly to AI cases without substantial revision. The overall conclusion is that the emergence of AI's own ethics would place significant pressure on current frameworks and may require substantial refinement, reconstruction, or reconceptualisation.

cs.AI

AI Morbidity and Mortality: A Framework for Clinical AI Failure Review

Clinical artificial intelligence is increasingly embedded in real-world care, yet existing safety mechanisms are poorly suited to reconstructing and learning from individual AI-related errors and near-misses. Aggregate model monitoring can identify performance changes, and traditional patient safety reporting can capture adverse events, but neither is designed to explain how risk emerges across the interaction among AI systems, clinicians, workflows, and institutional controls. We propose AI Morbidity and Mortality (AI M&M), a structured, blameless framework for case-based review of clinical AI failures. The framework combines standardized case intake, evidence preservation and investigator-level reconstruction, tool-in-loop attribution, and corrective-action tracking. Each event is classified across four linked dimensions: Trigger - Mechanism - Clinical Pathway - Corrective Action, separating the condition that exposed a vulnerability from the process that produced risk, its consequence for care, and the remediation assigned. We demonstrate the framework using five illustrative outpatient medication and clinical decision-support cases; two clinician reviewers independently applied all four classification axes and reached agreement across all 20 axis-level classifications. AI M&M is intended to complement, rather than replace, model monitoring, patient safety reporting, and regulatory oversight by converting individual AI-in-workflow failures into actionable institutional learning. Prospective evaluation across institutions, AI systems, and clinical settings is needed.

cs.AI